Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-hodgkin’s lymphoma

By Sparano Joseph   Negassa Abdissa   Lansigan Erick   Locke Robin   Silva Chamath   Wiernik Peter  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 257-267

Humana Press, Inc

Access to resources Recommend Favorite

Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis

By Sprinzl G.M.   Galvan O.   de Vries A.   Ulmer H.   Gunkel A.R.   Lukas P.   Thumfart W.F.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2003-2009

Elsevier

Access to resources Recommend Favorite

A phase I study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support in the treatment of advanced non-small cell lung cancer

By Mori K.   Hirose T.   Machida S.   Yokoyama K.   Tominaga K.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 503-505

Elsevier

Access to resources Recommend Favorite

Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 and granulocyte-macrophage colony stimulating factor (GM-CSF): II. Adverse effects of GM-CSF

By          

International Journal of Oncology, Vol. 40, Iss. 6, 2012-01 ,pp. : 1915-1922

Spandidos Publications

Access to resources Recommend Favorite

Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutro-penic cancer patients

By Ibrahim Ezzeldin   Al-Mulhim Fatma  

Medical Oncology, Vol. 14, Iss. 1, 1997-03 ,pp. : 47-51

Humana Press, Inc

Access to resources Recommend Favorite